查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386608

全球过敏诊断与治疗市场：趋势、预测与竞争分析（~2030 年）

Allergy Diagnostics and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

过敏诊断和治疗的趋势和预测

预计2024年至2030年全球过敏诊断和治疗市场规模将以6.5%的年复合成长率成长，到2030年将达到约554亿美元。该市场的主要驱动力是儿童和老年人群过敏性疾病的增加、IDV 技术的日益采用以及诊断工具的改进。全球过敏诊断和治疗市场前景广阔，食品、吸入和药品市场蕴藏商机。

过敏诊断和治疗市场洞察

Lucintel 预测，消耗品诊断测试消耗品的消耗品的采用率不断增加，消耗品预计将在预测期内实现最高成长。

在这个市场中，由于患者获得治疗的机会增加以及对药物过敏的认识提高，药物过敏预计将出现最高的增长。

由于过敏病例数量不断增加以及该地区政府的良好配合措施，预计北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业有何影响？

目录

第1章执行摘要

第2章全球过敏诊断与治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球过敏诊断和治疗市场趋势（2018-2023）和预测（2024-2030）
  • 按产品类型分類的全球过敏诊断和治疗市场
    • 装置
    • 消耗品
    • 服务
  • 按过敏原类型分類的全球过敏诊断和治疗市场
    • 食品
    • 吸入
    • 药品
  • 按测试类型分類的全球过敏诊断和治疗市场
    • In vivo Test
    • In vitro Test
  • 全球过敏诊断与治疗市场：依药物类别
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球过敏诊断和治疗市场按地区划分
  • 北美过敏诊疗市场
  • 欧洲过敏诊断与治疗市场
  • 亚太过敏诊断及治疗市场
  • 其他地区过敏诊疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球过敏诊断和治疗市场成长机会
    • 按过敏原类型分類的全球过敏诊断和治疗市场成长机会
    • 按测试类型分類的全球过敏诊断和治疗市场成长机会
    • 按药物类别分類的全球过敏诊断和治疗市场成长机会
    • 按地区分類的全球过敏诊断和治疗市场成长机会
  • 全球过敏诊疗市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球过敏诊疗市场产能
    • 全球过敏诊断和治疗市场的合併和收购
    • 认证和许可

第7章主要企业概况

  • R-Biopharm
  • EUROIMMUN Medizinische Labordiagnostika
  • DASIT
  • AESKU
  • BioMerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics
简介目录

Allergy Diagnostics and Therapeutics Trends and Forecast

The future of the global allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets. The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

A more than 150-page report is developed to help in your business decisions.

Allergy Diagnostics and Therapeutics by Segment

The study includes a forecast for the global allergy diagnostics and therapeutics by product type, allergen type, test type, drug class, and region.

Allergy Diagnostics and Therapeutics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Allergy Diagnostics and Therapeutics Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug

Allergy Diagnostics and Therapeutics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • In Vivo Test
  • In Vitro Test

Allergy Diagnostics and Therapeutics Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-Cholinergic
  • Immuno-Modulators
  • Epinephrine
  • Immunotherapy

Allergy Diagnostics and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Allergy Diagnostics and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies allergy diagnostics and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the allergy diagnostics and therapeutics companies profiled in this report include-

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics

Allergy Diagnostics and Therapeutics Market Insights

Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Within this market, drug allergies is expected to witness highest growth due to increasing access to treatment and rising awareness of drug allergies among patients.

North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Features of the Global Allergy Diagnostics and Therapeutics Market

Market Size Estimates: Allergy diagnostics and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Allergy diagnostics and therapeutics market size by various segments, such as by product type, allergen type, test type, drug class, and region in terms of value ($B).

Regional Analysis: Allergy diagnostics and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, allergen types, test types, drug classes, and regions for the allergy diagnostics and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the allergy diagnostics and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the allergy diagnostics and therapeutics market size?

Answer: The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030.

Q.2 What is the growth forecast for allergy diagnostics and therapeutics market?

Answer: The global allergy diagnostics and therapeutics market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the allergy diagnostics and therapeutics market?

Answer: The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

Q4. What are the major segments for allergy diagnostics and therapeutics market?

Answer: The future of the allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key allergy diagnostics and therapeutics market companies?

Answer: Some of the key allergy diagnostics and therapeutics companies are as follows:

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer
  • Minaris Medical America
  • Siemens Healthcare
  • Omega Diagnostics

Q6. Which allergy diagnostics and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Q7. In allergy diagnostics and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the allergy diagnostics and therapeutics market by product type (instruments, consumables, and services), allergen type (food, inhaled, and drug), test type (in vivo test and in vitro test), drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic, immuno-modulators, epinephrine, and immunotherapy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Allergy Diagnostics and Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Allergy Diagnostics and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Allergy Diagnostics and Therapeutics Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Services
  • 3.4: Global Allergy Diagnostics and Therapeutics Market by Allergen Type
    • 3.4.1: Food
    • 3.4.2: Inhaled
    • 3.4.3: Drug
  • 3.5: Global Allergy Diagnostics and Therapeutics Market by Test Type
    • 3.5.1: In vivo Test
    • 3.5.2: In vitro Test
  • 3.6: Global Allergy Diagnostics and Therapeutics Market by Drug Class
    • 3.6.1: Antihistamines
    • 3.6.2: Decongestants
    • 3.6.3: Corticosteroids
    • 3.6.4: Mast Cell Stabilizers
    • 3.6.5: Leukotriene Inhibitors
    • 3.6.6: Nasal Anti-cholinergic
    • 3.6.7: Immuno-modulators
    • 3.6.8: Epinephrine

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Allergy Diagnostics and Therapeutics Market by Region
  • 4.2: North American Allergy Diagnostics and Therapeutics Market
    • 4.2.2: North American Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.3: European Allergy Diagnostics and Therapeutics Market
    • 4.3.1: European Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.3.2: European Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.4: APAC Allergy Diagnostics and Therapeutics Market
    • 4.4.1: APAC Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.4.2: APAC Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug
  • 4.5: ROW Allergy Diagnostics and Therapeutics Market
    • 4.5.1: ROW Allergy Diagnostics and Therapeutics Market by Product Type: Instruments, Consumables, and Services
    • 4.5.2: ROW Allergy Diagnostics and Therapeutics Market by Allergen Type: Food, Inhaled, and Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Allergen Type
    • 6.1.3: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Test Type
    • 6.1.4: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Drug Class
    • 6.1.5: Growth Opportunities for the Global Allergy Diagnostics and Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Allergy Diagnostics and Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Allergy Diagnostics and Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Allergy Diagnostics and Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: R-Biopharm
  • 7.2: EUROIMMUN Medizinische Labordiagnostika
  • 7.3: DASIT
  • 7.4: AESKU
  • 7.5: BioMerieux
  • 7.6: Thermo Fisher Scientific
  • 7.7: Stallergenes Greer
  • 7.8: Minaris Medical America
  • 7.9: Siemens Healthcare
  • 7.10: Omega Diagnostics